Cargando…

PRAME expression and clinical outcome of breast cancer

The tumour antigen PReferentially expressed Antigen of MElanoma (PRAME) is expressed in a variety of malignancies, including breast cancer. We have analysed PRAME gene expression in relation to clinical outcome for 295 primary breast cancer patients. Kaplan–Meier survival curves show a correlation o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Epping, M T, Hart, A A M, Glas, A M, Krijgsman, O, Bernards, R
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2008
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527791/ https://www.ncbi.nlm.nih.gov/pubmed/18648365 http://dx.doi.org/10.1038/sj.bjc.6604494

Ejemplares similares

A Comprehensive Preclinical Model Evaluating the Recombinant PRAME Antigen Combined With the AS15 Immunostimulant to Fight Against PRAME-expressing Tumors
por: Gérard, Catherine, et al.
Publicado: (2015)

PRAME expression is similar in scar and desmoplastic melanoma
por: Plotzke, Jaclyn M., et al.
Publicado: (2022)

PRAME expression and promoter hypomethylation in epithelial ovarian cancer
por: Zhang, Wa, et al.
Publicado: (2016)

Lack of PRAME Expression in Cutaneous T-Cell Lymphomas
por: Bui, Chau M., et al.
Publicado: (2021)

PRAME Gene Expression in Acute Leukemia and Its Clinical Significance
por: Ding, Kai, et al.
Publicado: (2012)

PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer
por: van Amerongen, Rosa A., et al.
Publicado: (2023)

Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia
por: Wadelin, Frances, et al.
Publicado: (2010)

Clinical outcome data for symptomatic breast cancer: the breast cancer clinical outcome measures (BCCOM) project
por: Bates, T, et al.
Publicado: (2009)

PRAME Expression in Mucosal Melanoma of the Head and Neck Region
por: Ricci, Costantino, et al.
Publicado: (2023)

PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer
por: Al-Khadairi, Ghaneya, et al.
Publicado: (2019)

Metastatic PRAME-Expressing Juvenile Spitzoid Melanoma on the Buttock
por: Muto, Yusuke, et al.
Publicado: (2020)

PRAME protein expression in DICER1‐related tumours
por: Thorner, Paul S, et al.
Publicado: (2022)

PRAME Expression as Helpful Immunohistochemical Marker in Rhabdoid Melanoma
por: Glutsch, Valerie, et al.
Publicado: (2022)

PRAME protein expression in DICER1‐related tumours
por: Thorner, Paul S, et al.
Publicado: (2022)

Molecular and clinicopathological implications of PRAME expression in adult glioma
por: Le, Minh-Khang, et al.
Publicado: (2023)

PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy
por: Luk, Sietse J, et al.
Publicado: (2018)

PRAME induces genomic instability in uveal melanoma
por: Kurtenbach, Stefan, et al.
Publicado: (2023)

Correlation of preferentially expressed antigen of melanoma (PRAME) gene expression with clinical characteristics in acute leukemia patients
por: Kulkarni, Nagaraj V., et al.
Publicado: (2022)

HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME)
por: Grillini, Marco, et al.
Publicado: (2022)

One-stop diagnostic breast clinics: how often are breast cancers missed?
por: Britton, P, et al.
Publicado: (2009)

The Expansion of the PRAME Gene Family in Eutheria
por: Chang, Ti-Cheng, et al.
Publicado: (2011)

Validity of the online PREDICT tool in older patients with breast cancer: a population-based study
por: de Glas, N A, et al.
Publicado: (2016)

Biology of primary breast cancer in older women treated by surgery: with correlation with long-term clinical outcome and comparison with their younger counterparts
por: Syed, B M, et al.
Publicado: (2013)

Cancer Testis Antigens and Immunotherapy: Expression of PRAME Is Associated with Prognosis in Soft Tissue Sarcoma
por: Albertsmeier, Markus, et al.
Publicado: (2020)

Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre
por: Syed, B M, et al.
Publicado: (2011)

Analyses of Molecular and Histopathologic Features and Expression of PRAME by Immunohistochemistry in Mucosal Melanomas
por: Toyama, Aimi, et al.
Publicado: (2019)

Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma
por: Dyrskjøt, L, et al.
Publicado: (2012)

Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer
por: Barton, S, et al.
Publicado: (2012)

Early onset of breast cancer in a group of British black women
por: Bowen, R L, et al.
Publicado: (2008)

The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer
por: Lammers, L A, et al.
Publicado: (2010)

In vivo immuno-targeting of an extracellular epitope of membrane bound preferentially expressed antigen in melanoma (PRAME)
por: Pankov, Dmitry, et al.
Publicado: (2017)

The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer
por: Xu, Yichi, et al.
Publicado: (2020)

Cancer testis antigen PRAME: An anti‐cancer target with immunomodulatory potential
por: Naik, Adviti, et al.
Publicado: (2021)

Preferentially Expressed Antigen of Melanoma (PRAME) and Wilms’ Tumor 1 (WT 1) Genes Expression in Childhood Acute Lymphoblastic Leukemia, Prognostic Role and Correlation with Survival
por: Khateeb, Engy El, et al.
Publicado: (2014)

A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancer
por: Glover, J A, et al.
Publicado: (2011)

Effects of specialisation on treatment and outcomes in screen-detected breast cancers in Wales: cohort study
por: Allgood, P C, et al.
Publicado: (2006)

Bone marrow micrometastases in early breast cancer–30-year outcome
por: Mansi, J, et al.
Publicado: (2016)

Chronic preoperative pain and psychological robustness predict acute postoperative pain outcomes after surgery for breast cancer
por: Bruce, J, et al.
Publicado: (2012)

A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unit
por: Brunetto, A T, et al.
Publicado: (2010)

Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes
por: Roszik, Jason, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_64tmtp49jqg9jslvfd29mq3qs2